Ticker: VTGN

Company Overview Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company focused on developing non-systemic intranasal treatment options targeting CNS disorders via their proprietary pherine technology. The company's pipeline includes multiple product candida...